Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My takeaway from SA articles .......Disclosure: I am/we are long AVXL.
My takeaway from SA articles .......Disclosure: I am/we are long AVXL.
I agree... just think we close closer to .80.
News would have hit the radar and Bio funds will take a piece of AVXL. IMO
You really have that pitch down...LoL
Lincoln Park getting their $10 mil back.
SA article needs to address patent issue. Hopefully the good doctor will ease concerns.
Three things I learned today...
1. We have a drug with great potential
2, posters do not generate press releases from the AAIC
3. I will always trust the Good Doctor
Good luck to all.
You said it all.
I gave you a like.
“It seems to be hitting the receptors that it is meant to and be having the desired result in improving brain activity,” Prof Macfarlane said.
Says it all
Next resistance .6830 200 day weekly...IMO
Until we get up listed the MM's have control.
On good news they need to cover the shorts at the best possible price.
This was great news today. We should see some very positive PR in the next few days.
BTW you are one of the stars of this board
MM's covering shorts....
Great news....
Good luck to all
Upcoming SA article should give us a lot more traction. IMO
Congrats you just earned my IGNORE!
Looks like Kanak Kanti De: (our SA guy) is waiting for news before he presents article.
You should do stand up...LOL
The more shorts we have....the bigger the pop! Bring them on!
I want to thank all on this board that have contributed to our better understanding of all the issues and opportunities surrounding AVXL.
Next week should be exciting.
Have a great weekend.
Bought my last piece @ .46.
I am all in.
This is a biotech but IMHO the odds are in our favor.
I am long and strong and would love to sell Gordon some of my shares when he gets squeezed hard.
would it make sense for them to get involved before Piii. That was my point.
They did take blood samples in P11a.
The poster talks about biomarkers.
Possible they were involved.
They did take blood samples in P11a.
The poster talks about biomarkers.
Possible they were involved.
Our PR guys need to learn how to play the social media game.
Changes in Electrophysiological Markers in Alzheimer’s Disease
http://www.sciencedirect.com/science/article/pii/S106474811261197X
Guilty
I hope you are short
From my understanding of the last prospectus they have 10 trading days and can buy up to 100K a day as long as price stays above .50
Pros
Promising Platform
Good Doctor buying shares
Results being presented early
Strong management
Cons
Lots of .30 warrants
Another 1 mil shares being sold to Lincoln Park before the 22nd
This is a Biotech….anything can happen!
MM’s in control until they are not
If the results are positive and prove the platform to be as effective on humans as it was on the mouse models, the PPS should have a very nice pop, and a partnership with big pharma insured. IMHO
Good luck to all
Question to the board.
What if the results show it being more effective than the AXON drug.
Were do we trade?
The notice of effectiveness is a public declaration by the Securities and Exchange Commission that a public company's registration statement has been accepted.
My mistake.
The good doctor is exercising options
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) (1) Common Stock 200000 $0.42
Good Phase 2 results = partnership (buyout leaves too much $$$ on the table IMHO)
Phase 2 will validate the platform
Warrants being flipped.... .30's @ .45 = 50% gain
My understanding is the July 22nd release will be for phase 2a. They need to complete the study per the plan they set forth.
IMHO the results will be good.
Good luck to all.
To be relevant they need to show results from more than one patient. In this case first means first study results (from multiple patients)
The multicenter Phase 2a clinical trial of ANAVEX 2-73 consists of two parts, in which at least 32 mild to moderate Alzheimer’s patients will be enrolled. The first part (PART A) is a simple randomized, open-label, two-period, cross-over, adaptive trial lasting up to 36 days for each patient. The second part (PART B) is an open-label extension for an additional 26 weeks, so as to establish a longer drug effect for the patients who wish to continue on an oral daily dose.
This is from press release.... multiple patients over a 36 day period
Pretty orderly distribution of warrants.
We could use some news.